J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 130-137

  Xiao, He ^a   Zhang, Han ^b   Yu, Zu Yin ^c   Zhang, Lei ^a   Yu, Ming ^a   Huang, Yi Fei ^b   Li, Song ^d   Shen, Bei Fen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

CD4+ T cells; Corneal allograft rejection; Functional assays; Immunosuppressive agent; New CD4 D1 inhibitor

Indexed keywords

'J2'; IMMUNOSUPPRESSIVE AGENT; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG EFFECT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACRYLAMIDES; ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CORNEAL TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; INDOLES; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; TH1 CELLS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 36048932729     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.05.013     Document Type: Article

References (55)

1. Smith R.E., McDonald H.R., Nesburn A.B., and Minckler D.S. Penetrating keratoplasty: changing indications, 1947 to 1978. Arch Ophthalmol 98 (1980) 1226-1229
2. Rocha G., Deschenes J., and Rowsey J.J. The immunology of corneal graft rejection. Crit Rev Immunol 18 (1998) 305-325
3. Aldredge O.C., and Krachmer J.H. Clinical corneal transplant rejection: their manifestations, frequency, preoperative correlates and treatment. Arch Ophthalmol 99 (1981) 599-610
4. Lindstrom R.L. Advances in corneal transplantation. N Engl J Med 315 (1986) 57-59
5. Williams K.A., Roder D., Esterman A., Muehlberg S.M., and Coster D.J. Factors predictive of corneal graft survival. Ophthalmology 99 (1992) 403-414
6. Maguire M.G., Stark W.J., Gottsch J.D., Stulting R.D., Sugar A., Fink N.E., et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 101 (1994) 1536-1547
7. Pepose J.S., Nestor M.S., Gardner K.M., Foos R.Y., and Pettit T.H. Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch Clin Exp Ophthalmol 222 (1985) 128-133
8. Williams K.A., Standfield S.D., Wing S.J., Barras C.W., Mills R.A., Comacchio R.M., et al. Patterns of corneal graft rejection in the rabbit and reversal of rejection with monoclonal antibodies. Transplantation 54 (1992) 38-43
9. Wackenheim-Urlacher A., Kantelip B., Falkenrodt A., Piqot X., Tongio M.M., Montard M., et al. T-cell repertoire of normal, rejected, and pathological corneas: phenotype and function. Cornea 14 (1995) 450-456
10. Sonoda Y., Sano Y., Ksander B., and Streilein J.W. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ohthalmol Vis Sci 36 (1995) 427-434
11. Larkin D.F., Calder V.L., and Lightman S.L. Identification and characterization of cells infiltrating the graft and aqueous humor in rat corneal allograft rejection. Clin Exp Immunol 107 (1997) 381-391
12. Larkin D.F., Alexander R.A., and Cree I.A. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye 11 (1997) 68-74
13. Yamagami S., Tsuru T., Ohkawa T., Endo H., and Isobe M. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation. Transplantation 67 (1999) 600-604
14. Sonoda Y., and Streilein J.W. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 150 (1993) 1727-1734
15. Joo C.K., Pepose J.S., and Stuart P.M. T cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 36 (1995) 1530-1540
16. Yao Y.F., Inoue Y., Miyazaki D., Hara Y., Shimomura Y., Tano Y., et al. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice. Invest Ophthalmol Vis Sci 38 (1997) 292-300
17. Hegde S., and Niederkorn J.Y. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci 41 (2000) 3341-3347
18. Yamada J., Ksander B.R., and Streilein J.W. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 42 (2001) 386-392
19. He Y.G., Ross J., and Niederkorn J.Y. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 32 (1991) 2723-2728
20. Ayliffe W., Alam Y., Bell E.B., McLeod D., and Hutchinson I.V. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 76 (1992) 602-606
21. + T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 40 (1999) 2614-2621
22. + T cells are critical for corneal, but not skin, allograft rejection. Transplantation 69 (2000) 483-487
23. Littman D.R. The structure of the CD4 and CD8 genes. Annu Rev Immunol 5 (1987) 561-584
24. Wang J.H., Yan Y.W., Garrett T.P., Liu J.H., Rodgers D.W., Garlick R.L., et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348 (1990) 411-418
25. Wu H., Kwong P.D., and Hendrickson W.A. Dimeric association and segmental variability in the structure of human CD4. Nature (London) 387 (1997) 527-530
26. Konig R., Shen X., and Germain R.N. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J Exp Med 182 (1995) 779-787
27. Wang J.H., Meijers R., Xiong Y., Liu J.H., Sakihama T., Zhang R., et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A 98 (2001) 10799-10804
28. Xiao H., Feng J.N., He X.H., Zhang H., Zhang J.R., Zhang L., et al. Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1. Mol Immunol 44 (2007) 784-795
29. Zhang E.P., Schrunder S., and Hoffmann F. Orthotopic corneal transplantation in the mouse: a new surgical technique with minimal endothelial cell loss. Graefes Arch Clin Exp Ophthalmol 234 (1996) 714-719
30. Sonoda Y., and Streilein J.W. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation 54 (1992) 694-704
31. Plskova J., Kuffova L., Holan V., Filipec M., and Forrester J.V. Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol 86 (2002) 108-113
32. Morel P.A., and Oriss T.B. Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18 (1998) 275-303
33. Sano Y., Osawa H., Sotozono C., and Kinoshita S. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci 39 (1998) 1953-1957
34. Yamagami S., Kawashima H., Endo H., Tsuru T., Shibui H., Kagawa Y., et al. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation 66 (1998) 1504-1510
35. Iwamoto T., and Smelser G.K. Electron microscope studies on the mast cells and blood and lymphatic capillaries of the human corneal limbus. Invest Ophthalmol 4 (1965) 815-834
36. Streilein J.W., Toews G.B., and Bergstresser P.R. Corneal allografts fail to express Ia antigens. Nature 282 (1979) 326-327
37. Gebhardt B.M. The role of class II antigen-expressing cells in corneal allograft immunity. Invest Ophthalmol Vis Sci 31 (1990) 2254-2260
38. Jager M.J., Bradley D., and Streilein J.W. Immunosuppressive properties of cultured human cornea and ciliary body in normal and pathological conditions. Transpl Immunol 3 (1995) 135-142
39. Nishida K., Sotozono C., Adachi W., Yamamoto S., Yokoi N., and Kinoshita S. Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res 14 (1995) 235-241
40. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
41. Wilson S.E., Li Q., Weng J., Barry-Lane P.A., Jester J.V., Liang Q., et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci 37 (1996) 1582-1592
42. Stuart P.M., Griffith T.S., Usui N., Pepose J., Yu X., and Ferguson T.A. CD95 ligand (FasL) induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99 (1997) 396-402
43. Yamagami S., Kawashima H., Tsuru T., Yamagami H., Kayagaki N., Yagita H., et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64 (1997) 1107-1111
44. Belin M.W., Bouchard C.S., and Phillips T.M. Update on topical cyclosporine A: background, immunology, and pharmacology. Cornea 9 (1990) 184-195
45. Raizman M. Corticosteroid therapy of eye disease. Fifty years later. Arch Ophthalmol 114 (1996) 1000-1001
46. He Y.G., Mellon J., and Niederkorn J.Y. The effect of oral immunization on corneal allograft survival. Transplantation 61 (1996) 920-926
47. Ma D., Mellon J., and Niederkorn J.Y. Oral immunisation as a strategy for enhancing corneal allograft survival. Br J Ophthalmol 81 (1997) 778-784
48. Ma D., Mellon J., and Niederkorn J.Y. Conditions affecting enhanced corneal allograft survival by oral immunization. Invest Ophthalmol Vis Sci 39 (1998) 1835-1846
49. Gebhardt B.M., Hodkin M., Varnell E.D., and Kaufman H.E. Protection of corneal allografts by CTLA4-Ig. Cornea 18 (1999) 314-320
50. Qian Y., Boisgerault F., Benichou G., and Dana M.R. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci 42 (2001) 987-994
51. Yamada J., Yoshida M., Taylor A.W., and Streilein J.W. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol 162 (1999) 5247-5255
52. He Y.G., Mellon J., Apte R., and Niederkorn J.Y. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest Ophthalmol Vis Sci 35 (1994) 3218-3225
53. Dana M.R., Yamada J., and Streilein J.W. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation 63 (1997) 1501-1507
54. Zhang E.P., Pohl T., Bulfone-Paus S., Wachtlin J., Kunzendorf U., and Hoffmann F. Prolongation of corneal allograft survival by an interleukin-2-immunoglobulin fusion protein in mice. Graefes Arch Clin Exp Ophthalmol 236 (1998) 486-492
55. Thiel M.A., Coster D.J., and Williams K.A. The potential of antibody-based immunosuppressive agents for corneal transplantation. Immunol Cell Biol 81 (2003) 93-105